Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2014
10/30/2014US20140323501 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof
10/30/2014US20140323487 Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors
10/30/2014US20140323486 Heterocyclic urea compounds
10/30/2014US20140323483 Type iii secretion inhibitors, analogs and uses thereof
10/30/2014US20140323473 Compounds and methods to treat organophosphorus poisoning
10/30/2014US20140323461 Phenyl-Substituted Nicotinic Ligands, and Methods of Use Thereof
10/30/2014US20140323390 Compounds and compositions as tlr2 agonists
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871981 Method for oxidizing alcohols
10/28/2014US8871976 Chalcone structure fluorescence dye for embryonic stem cell probe
10/28/2014US8871943 Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871768 Certain chemical entities, compositions and methods
10/28/2014US8871747 Urea and thiourea derivatives
10/23/2014US20140316139 Tricyclic Compounds, Compositions, And Methods
10/23/2014US20140315960 Prodrugs of non-steroid anti-inflammatory agents (nsaids)
10/23/2014US20140315959 Treatment of ovarian cancer with benzylidenebenzohydrazides
10/23/2014US20140315958 4-[4-(amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide monohydrate
10/23/2014US20140315954 Cytotoxic and anti-mitotic compounds, and methods of using the same
10/23/2014US20140315950 New lipogenesis inhibitor compounds
10/23/2014US20140315949 Modulators of methyl modifying enzymes, compositions and uses thereof
10/23/2014US20140315915 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
10/23/2014US20140315913 Substituted pyridine and pyrazine compounds as pde4 inhibitors
10/23/2014US20140315905 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2014US20140315903 1, 4-Disubstituted 3-Cyano-Pyridone Derivatives and Their Use As Positive Allosteric Modulators of MGLUR2-Receptors
10/23/2014US20140315898 N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
10/23/2014US20140315884 Ampk-activating heterocyclic compounds and methods for using the same
10/23/2014US20140315879 Sulfonamide Derivatives
10/23/2014US20140315878 Chemical compounds
10/21/2014US8865908 Process for the preparation of a 2-pyridylethylcarboxamide derivative
10/21/2014US8865907 Method of producing pyrone and pyridone derivatives
10/21/2014US8865905 Organic compounds
10/21/2014US8865901 Gain-of-function Bcl-2 inhibitors
10/21/2014US8865771 Amides useful as inhibitors of voltage-gated sodium channels
10/21/2014US8865748 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
10/21/2014US8865742 Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865714 Piperazine compound capable of inhibiting prostaglandin D synthase
10/21/2014US8864848 Zwitterionic azo dyestuffs for coloring keratin-including fibres
10/16/2014US20140309426 Pharmaceutical compositions for the treatment of left ventricular diastolic dysfunction comprising an apolipoprotein peptide/phospholipid complex
10/16/2014US20140309264 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
10/16/2014US20140309228 Quaternized amines as sodium channel blockers
10/16/2014US20140309225 Novel nicotinamide derivative or salt thereof
10/16/2014US20140309192 Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
10/16/2014US20140308317 Polymeric Compounds And Methods Of Making And Using The Same
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859798 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
10/14/2014US8859778 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859620 Phthalanilate compounds and methods of use
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859594 Polymorphs of N-(6-(4-chlorophenoxy)hexyl)-N′-cyano-N″-(4-pyridyl)guanidine, and preparation thereof and use thereof
10/14/2014US8859590 Inhibitors of BACE1 and methods for treating Alzheimer's disease
10/14/2014US8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
10/14/2014US8859559 Substituted pyrazines and their use in the treatment of disease
10/14/2014US8859556 TRPA1 receptor antagonist
10/14/2014US8859546 Picolinamide inhibitors of kinases
10/14/2014US8859541 6-alkynylpyridines
10/14/2014US8859539 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders
10/14/2014US8859505 Cysteine protease inhibitors
10/14/2014US8859494 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
10/09/2014WO2014165827A1 Ppar agonists
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014162105A1 Lanthanide complexes comprising at least two betaine groups, which can be used as luminescent markers
10/09/2014WO2014161850A1 Process for the preparation of amides from hindered anilines containing a perhaloalkyl group
10/09/2014WO2014161849A1 Insecticidal compounds
10/09/2014WO2014161848A1 Insecticidal compounds
10/09/2014US20140303377 Agricultural/horticultural insecticide and method for using the same
10/09/2014US20140303333 Iron bisphenolate complexes and methods of use and synthesis thereof
10/09/2014US20140303175 2-Substituted-3-Phenylpropionic Acid Derivatives and Their Use in the Treatment of Inflammatory Bowel Disease
10/09/2014US20140303167 Cdk9 inhibitors in the treatment of midline carcinoma
10/09/2014US20140303151 Inhibitors of PI3K-Delta and Methods of Their Use and Manufacture
10/09/2014US20140301999 Biaryl pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
10/09/2014US20140301979 Anti-arenaviral compounds
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2786983A1 Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof
10/08/2014EP2786135A1 Benzyl-pyridinium and -imidazolinium ionic liquid salts for use in planar chromatography
10/07/2014USRE45183 Heteroaryl-ureas and their use as glucokinase activators
10/07/2014US8853450 Nitrile hydration catalyzed by recyclable ruthenium complexes
10/07/2014US8853440 Method for producing amide derivative
10/07/2014US8853409 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
10/07/2014US8853392 Benzamide mGluR5 positive allosteric modulators and methods of making and using same
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853270 Substituted stilbenes and their reactions
10/07/2014US8853258 C-linked hydroxamic acid derivatives useful as antibacterial agents
10/07/2014US8853243 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
10/07/2014US8853230 Inhibitors of JAK
10/07/2014US8853218 Compounds
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/07/2014US8852553 N-alkoxyamide conjugates as imaging agents
10/02/2014WO2014160185A2 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
10/02/2014WO2014159657A1 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
10/02/2014WO2014158654A1 Ship1 modulators and methods related thereto
10/02/2014WO2014157672A1 Substituted biaryl compound
10/02/2014WO2014155301A1 Substituted bicyclic compounds as inhibitors of ezh2
10/02/2014WO2014154794A1 Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
10/02/2014US20140296534 Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 633